These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27493325)

  • 1. Drug-resistant malaria in Sudan: A review of evidence and scenarios for the future.
    Adeel AA
    Sudan J Paediatr; 2012; 12(1):8-20. PubMed ID: 27493325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.
    Adeel AA; Elnour FA; Elmardi KA; Abd-Elmajid MB; Elhelo MM; Ali MS; Adam MA; Atta H; Zamani G; Warsame M; Barrette A; Mohammady HE; Nada RA
    Malar J; 2016 May; 15(1):285. PubMed ID: 27209063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacies of DHA-PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan.
    Mohamed AO; Abdel Hamid MM; Mohamed OS; Elkando NS; Suliman A; Adam MA; Elnour FAA; Malik EM
    Malar J; 2017 Apr; 16(1):163. PubMed ID: 28427409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations.
    Hamour S; Melaku Y; Keus K; Wambugu J; Atkin S; Montgomery J; Ford N; Hook C; Checchi F
    Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):548-54. PubMed ID: 15869770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
    Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
    Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History and importance of antimalarial drug resistance.
    D'Alessandro U; Buttiëns H
    Trop Med Int Health; 2001 Nov; 6(11):845-8. PubMed ID: 11703837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis.
    A-Elbasit IE; Elbashir MI; Khalil IF; Alifrangis M; Giha HA
    Trop Med Int Health; 2006 May; 11(5):604-12. PubMed ID: 16640612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of point mutations in dihydrofolate reductase genes and multidrug resistance gene 1-86 on treatment of falciparum malaria in Sudan.
    Yusuf RU; Omar SA; Ngure RM
    J Infect Dev Ctries; 2010 Mar; 4(2):61-9. PubMed ID: 20212335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SP.
    Kolaczinski K; Leslie T; Ali I; Durrani N; Lee S; Barends M; Beshir K; Ord R; Hallett R; Rowland M
    PLoS One; 2012; 7(1):e28957. PubMed ID: 22303437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance.
    Mita T; Tanabe K
    Jpn J Infect Dis; 2012; 65(6):465-75. PubMed ID: 23183197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.
    Tjitra E; Baker J; Suprianto S; Cheng Q; Anstey NM
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3947-53. PubMed ID: 12435700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.
    Bakhiet AMA; Abdelraheem MH; Kheir A; Omer S; Gismelseed L; Abdel-Muhsin AA; Naiem A; Al Hosni A; Al Dhuhli A; Al Rubkhi M; Al-Hamidhi S; Gadalla A; Mukhtar M; Sultan AA; Babiker HA
    Trans R Soc Trop Med Hyg; 2019 Nov; 113(11):693-700. PubMed ID: 31369106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroquine and Sulfadoxine-Pyrimethamine Resistance in Sub-Saharan Africa-A Review.
    Roux AT; Maharaj L; Oyegoke O; Akoniyon OP; Adeleke MA; Maharaj R; Okpeku M
    Front Genet; 2021; 12():668574. PubMed ID: 34249090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia.
    Verdrager J
    J Trop Med Hyg; 1986 Dec; 89(6):277-89. PubMed ID: 3543384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin derivatives for treatment of uncomplicated Plasmodium falciparum malaria in Sudan: too early for too much hope.
    Giha HA
    Parasitol Res; 2010 Feb; 106(3):549-52. PubMed ID: 20012990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
    Durrani N; Leslie T; Rahim S; Graham K; Ahmad F; Rowland M
    Trop Med Int Health; 2005 Jun; 10(6):521-9. PubMed ID: 15941414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.